RecruitingNot ApplicableNCT05966311

Pediatric Percutaneous Ultrasound Gastrostomy Technique

A Multi-center, Feasibility Study to Evaluate the Use and Safety and of the Pediatric PUMA-G System for Percutaneous Ultrasound Gastrostomy


Sponsor

CoapTech

Enrollment

80 participants

Start Date

Jul 7, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this research study is to test a new device called the PUMA-G Pediatric System. The research will measure if the device works well to safely aid doctors placing gastrostomy feeding tubes in children. The PUMA-G Pediatric System is an investigational device that uses ultrasound and magnets to guide insertion of a feeding tube.


Eligibility

Min Age: 0 YearsMax Age: 21 Years

Inclusion Criteria11

  • Informed consent must be obtained from the patient or a Legally Authorized Representative (ex. parent/guardian) before any study-specific assessment is performed
  • Weight ≥5 (Phase 0, Phase 1, Phase 2)
  • Weight ≥3kg and <10kg (Phase 3)
  • Estimated abdominal wall thickness ≤3cm
  • Indication for gastrostomy tube placement, with or without jejunal access tubing via gastrostomy tract, determined to be present for any of the following reasons:
  • Anatomic: Ear, nose, or throat abnormalities (Pierre-Robin sequence cleft lip palate)
  • Neurologic: Head trauma, Cerebral palsy
  • Bowel Disease: Short Bowel syndrome, intestinal dysmotility, inflammatory bowel disease, malabsorption
  • Failure to Thrive: Cystic Fibrosis, Cholestasis, AID, Chronic renal failure, and food refusal
  • Patient determined to be an appropriate candidate for PUG, PEG, or PRG by the clinical care team
  • Anticipated discharge > 24 hrs following gastrostomy

Exclusion Criteria15

  • Temperature ≥ 38 C
  • Systolic BP < 80 or > 180 mmHg
  • Heart Rate < 50 or > 160
  • Estimated abdominal wall thickness >3cm
  • Coagulopathy defined by INR > 1.7 or Platelets <50,000
  • Presence of a contraindication to being in proximity to a magnet (e.g. implantable metallic device).
  • History of prior gastrostomy, gastrectomy (partial or complete), or abdominal trauma or upper-abdominal surgery.
  • Scoliosis
  • Atypical organ placement including microgastria
  • Involvement in other investigational trials within 30 days prior to screening,
  • Pregnant or nursing (lactating) women, where pregnancy is defined as the state of a female after conception and until the termination of gestation, confirmed by a positive hCG laboratory test
  • Patients with HgB < 7g/dL, or fluid resuscitated within 48hrs prior, or received blood transfusion within 48hrs prior, or active life threatening GI bleeding
  • Esophageal Diseases: Atresia, stricture, caustic ingestion
  • Spinal anomalies or atypical organ placement
  • Any other medical condition(s) that may put the patient at risk or influence study results in the investigator's opinion, based on the performance of a pre-procedural assessment.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPercutaneous Ultrasound Gastrostomy

Ultrasound guided placement of gastrostomy tube using the PUMA-G Pediatric System


Locations(3)

Children's National Hospital

Washington D.C., District of Columbia, United States

Nyph/Cumc

New York, New York, United States

Children's Hospital Of Phildelphia

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05966311


Related Trials